Literature DB >> 6478459

The conformation of Salmonella O-antigenic polysaccharide chains of serogroups A, B, and D1 predicted by semi-empirical, Hard-Sphere (HSEA) calculations.

K Bock, M Meldal, D R Bundle, T Iversen, P J Garegg, T Norberg, A A Lindberg, S B Svenson.   

Abstract

The preferred conformation of the tetrasaccharide repeating units of Salmonella Serogroups A, B, and D1 have been calculated. The semiempirical calculations used the Hard-Sphere, Exo-Anomeric (HSEA) approach to derive a conformational model, which could be used to assist the interpretation of conformations significantly populated in aqueous solution. The calculated model was extended to include a pentasaccharide repeating unit bearing an alpha-D-glucopyranose-branch point. The 3,6-dideoxyhexose to D-mannose linkage was shown to possess a steep energy surface with a minimum, which results in good exposure of the dideoxyhexose O-2 and O-4 atoms. Stereochemical changes involving the equatorial or axial disposition of these atoms are the distinguishing structural features of the A, B, and D1 serogroups. A lipophilic surface involving the 6-deoxy groups of the dideoxy-D-hexose and L-rhamnose residues was identified, and the possible implications of these features in antigenic determinants is discussed. The preferred conformation predicted by the HSEA method correlates with the known antigenic specificities of polysaccharides belonging to these Salmonella serogroups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478459     DOI: 10.1016/0008-6215(84)85267-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  9 in total

1.  Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

Authors:  E Konadu; J Shiloach; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Modeling antibody hypervariable loops: a combined algorithm.

Authors:  A C Martin; J C Cheetham; A R Rees
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Authors:  E Y Konadu; F Y Lin; V A Hó; N T Thuy; P Van Bay; T C Thanh; H B Khiem; D D Trach; A B Karpas; J Li; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Perspective on computational simulations of glycosaminoglycans.

Authors:  Balaji Nagarajan; Nehru Viji Sankaranarayanan; Umesh R Desai
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2018-09-10

5.  Molecular modelling of the three-dimensional structure and conformational flexibility of bacterial lipopolysaccharide.

Authors:  M Kastowsky; T Gutberlet; H Bradaczek
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

Review 6.  Diverse virulence traits underlying different clinical outcomes of Salmonella infection.

Authors:  J Fierer; D G Guiney
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

7.  Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.

Authors:  D C Watson; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Lysogenic conversion of Salmonella typhimurium bacteriophages A3 and A4 consists of O-acetylation of rhamnose of the repeating unit of the O-antigenic polysaccharide chain.

Authors:  R Wollin; B A Stocker; A A Lindberg
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

9.  Interaction of a Salmonella enteritidis O-antigen octasaccharide with the phage P22 tailspike protein by NMR spectroscopy and docking studies.

Authors:  Jens Landström; Eva-Lisa Nordmark; Robert Eklund; Andrej Weintraub; Robert Seckler; Göran Widmalm
Journal:  Glycoconj J       Date:  2007-08-17       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.